TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/20/24 17:20 | 2/15/24 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Clark David Michael | NJ | O | Chief Pe | S | -62 | 14.00 | 0 | -4 | -2 | 254 | D | ||||||||||||||
1/9/24 18:08 | 1/8/24 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Clark David Michael | NJ | O | Chief Pe | S.m | -142 | 14.00 | 0 | -10 | -4 | 267 | D | ||||||||||||||
1/19/23 18:16 | 1/18/23 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Clark David Michael | PA | O | Chief Pe | S | -100 | 13.50 | 0 | -7 | -3 | 241 | D | ||||||||||||||
1/6/23 17:03 | 1/6/23 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Clark David Michael | PA | O | Chief Pe | S | -255 | 11.87 | 0 | -22 | -9 | 220 | D | ||||||||||||||
1/4/23 19:21 | 1/3/23 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Clark David Michael | PA | O | Chief Pe | S.d | -102 | 12.03 | 0 | -8 | -3 | 244 | D | ||||||||||||||
2/14/20 16:21 | 2/12/20 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Clark David Michael | NJ | O | Chief Pe | S | -78 | 11.00 | 0 | -7 | -5 | 147 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |